Cargando…
Mouse models in the era of large human tumour sequencing studies
Cancer is a complex disease in which cells progressively accumulate mutations disrupting their cellular processes. A fraction of these mutations drive tumourigenesis by affecting oncogenes or tumour suppressor genes, but many mutations are passengers with no clear contribution to tumour development....
Autores principales: | de Ruiter, J. R., Wessels, L. F. A., Jonkers, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119864/ https://www.ncbi.nlm.nih.gov/pubmed/30111589 http://dx.doi.org/10.1098/rsob.180080 |
Ejemplares similares
-
Identifying transposon insertions and their effects from RNA-sequencing data
por: de Ruiter, Julian R., et al.
Publicado: (2017) -
XenofilteR: computational deconvolution of mouse and human reads in tumor xenograft sequence data
por: Kluin, Roelof J. C., et al.
Publicado: (2018) -
Genetically engineered mouse models in oncology research and cancer medicine
por: Kersten, Kelly, et al.
Publicado: (2016) -
Association Claims in the Sequencing Era
por: Pulit, Sara L., et al.
Publicado: (2014) -
Insertional mutagenesis in a HER2-positive breast cancer model reveals ERAS as a driver of cancer and therapy resistance
por: Ikink, Gerjon J., et al.
Publicado: (2018)